Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc Analysis | Advances in Wound Care
#ON101
https://t.co/nSkkXDKnVT
A US Phase II trial with 135 COVID-19 patients found that SNS812, an aerosolized antiviral, is safe and effective.
The 200mg dose cut viral load within a day, reduced clearance time from 3.6 to 2.9 days, and improved key symptoms.
https://t.co/89IHnDkDt6
Oneness Fespixon® has been out-licensed to CR Double- Crane for exclusive commercialization in China, a significant step forward of the blockbuster new drug’s global launch https://t.co/FF4zc08c1J
Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in A Randomized Phase III Trial
ON101 exhibits unique mechanism for remodeling the wound microenvironment, which could be an ideal treatment option for DFU patients on dialysis therapy.
https://t.co/xlquTGtnkF
Optimizing Wound Bed and Diabetic Foot Ulcer Healing with *Proprietary Natural Herbal Cream – A Case Series in US https://t.co/1IgtHT8qYd
#FESPIXON#BONVADIS#ON101
Tomorrow at #EASD2023👍 (pls share)
TIME: Thursday 5 Oct 2023 9:00-10:30
VENUE: Chicago Hall
Don’t miss it…. Best neuropathy picks, all you need to know🙃😉😉 -
It is all about The NeuroDiab symposium: “Diabetic neuropathy: New perspectives” -
▶️ Check #NeuroDiab2023 meeting
▶️ Program https://t.co/ArsAKU1tmf
ABOUT this symposium:
The @Neurodiab_eu symposium: “Diabetic neuropathy: New perspectives” will give you the best picks from this years #NeuroDiab2023 meeting held in Thessaloniki just prior to the #EASD2023, including highly specialized rundowns on epidemiology, diagnosis and treatment of diabetic neuropathy, delivered by global experts in this field.
ABOUT NeuroDiab:
#NeuroDiab2023 gathered attendees from +32 countries (including #ReunionIslands🇷🇪) and delivered 119 top quality presentation. All neuropathy experts, all devoted and dedicated to solving the most challenging and unforgiving complication of diabetes, attacking perhaps the most delicate and intricate of our organ systems.
@Neurodiab_eu builds and prospers from new and old friendships and the hallmark is #inclusion, with a particular focus on engaging and facilitating the professional development of our youngest colleagues👍
Together we move diabetic neuropathy forward for people with diabetes.
ABOUT neuropathy:
Nerve damage in diabetes affects up to half of all people with diabetes, and it may affect any part of the nervous system. It is without symptoms to begin with and therefore often goes unnoticed by people with diabetes. And some people may be seriously affected, while others go free. The reason why, remains an enigma. Of all consequences, the #Diabetic #Foot #Ulcer, is the most serious, a direct result of the reduced or often completely absent sensation in the feet - and this leads to #Amputations in far far to many people, incurring immense human sufferings, high costs to society and huge burdens for our healtcare system.
And adding to this, a great many people with diabetes may experience painful symptoms in their feet and legs, even if they have no sensation in their feet. These symptoms range from slight and bearable to excruciating and incapacitating, and there is no efficient treatment and we do not understand the pathophysiology.
https://t.co/sova5MVdDr
Kenyataan Media Kementerian Kesihatan Malaysia
Keputusan Mesyuarat Pihak Berkuasa Kawalan Dadah Kali Ke-386 Berkenaan Kelulusan Pendaftaran Pertama Bagi Produk Semulajadi Dengan Tuntutan Terapeutik
The natural product that has been granted with the registration was Fespixon cream, used for the treatment of diabetic foot ulcers. https://t.co/0Gjc795nZz
Great story by @SummerrLin! @LAGeneralMed is leading the way on innovation with a new care model: Safer At Home. Safer, more patient-centered, concierge care, normally only for the rich, now in the safety net. @ladhs@HildaSolis@LACountyBOS@LACountyCEO
https://t.co/RPVz3ozXin